Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish
  • Turkish

Breadcrumb

  1. Home
  2. Dermatology
  3. Atopic dermatitis: nasal and skin microbiomes associated with disease severity
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Dermatology
  3. Atopic dermatitis: nasal and skin microbiomes associated with disease severity

Atopic dermatitis: nasal and skin microbiomes associated with disease severity

Atopic dermatitis

The skin microbiome may not be the only one involved in the severity of atopic dermatitis: the nasal microbiome may also play a role. Although distinct, these two microbiomes are nonetheless linked.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail
Photo : Atopic dermatitis: nasal and skin microbiomes associated with disease severity

About this article

Created 22 January 2021
Updated 22 July 2024

Changes in the skin microbiome have been associated with atopic dermatitis (AD) and its severity. The nasal microbiota may also be involved: Staphylococcus aureus has been found five times more often in the nose of AD patients. The nostrils may be an important source of self-contamination and of bacterial propagation from the nose to the skin, or vice versa. A study has therefore focused on the relationship between skin and nasal microbiomes in children with AD, based on the severity of the disease.

Nose and skin: two connected microbiomes?

Using 16S-rRNA sequencing, the researchers first found distinct microbial communities in the nose (89 samples) and on the damaged skin (57 samples) of children with AD: while the nasal microbiome was dominated by Actinobacteria (Corynebacterium spp.), Proteobacteria (mainly Moraxella) and Firmicutes (Staphylococcus, Streptococcus and Dolosigranulum spp.), the skin lesions were dominated by staphylococci, and to a lesser extent by species belonging to the genera Pelomonas, Streptococcus and Janthinobacterium. However, correlations were found between the bacterial species in the nose and those on the skin, although the mechanisms involved are not fully understood (cross-transmission between the two niches?).

Microbiomes linked to disease severity

Most importantly, the compositions of the nasal and skin microbiomes, and particularly that of the skin microbiome, were both found to be linked to the severity of pediatric AD. This was so even after adjusting for confounding factors such as age, antibiotic use, and skin sample site. This link between the microbiomes and AD severity is mainly due to the presence of staphylococci in both niches, and of other species, such as Moraxella in the nose.

Distinguishing between bacterial presence and bacterial load

The study also showed that S. aureus was present in the skin lesions of one out of two patients–more often in (sidenote: Trend nevertheless statistically insignificant ) –but that its load (measured by quantitative PCR) was not associated with the severity of AD. Conversely, although the presence of S. epidermidis in the skin was not correlated with severity in 80% of the samples, its load was significantly higher in cases of severe AD. Even though this association does not demonstrate a causal link, the results suggest that the two microbial niches play a role in exacerbating inflammation caused by the disease. Hence the importance of exploring in future studies not only the role of microbial species in AD and their relationships with the host and other species, but also the interactions between the different microbial communities within the organism.

 

Sources

Totté JEE, Pardo LM, Fieten KB et al. Nasal and skin microbiomes are associated with disease severity in paediatric atopic dermatitis. Br J Dermatol. 2019 Oct;181(4):796-804.

Tags
Eczema Atopic Dermatitis Dermatology Microbiome Flora
    Created 22 January 2021
    Updated 22 July 2024

    About this article

    To know more about this topic.

    Main topic

    Atopic dermatitis

    Content type

    News

    The Janus face of Antibiotics: Life Savers and Microbiota Disruptors

    A page turns: with the advent of antibiotics in the...

    Find out more

    The infant's gut at the heart of immunity

    By Dr Travis J. De Wolfe

    Find out more

    Antibiotics, a double-edged sword when managing skin disease

    The effects of antibiotics on the skin microbiota have been studied mainly in the context of acne tre...

    Find out more

    Skin microbiota : which role in atopic dermatitis and acne?

    Literature selection By Pr Markku Voutilainen Turku University Faculty of Medicine; Turku University...

    Find out more

    Skin Microbiota #12

    By Prof. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Departme...

    Find out more

    Skin Microbiota #11

    By Prof. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Departme...

    Find out more

    Skin microbiota #10

    By Pr. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Department...

    Find out more

    Skin microbiota #13

    By Pr. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Department...

    Find out more

    Continue reading

    News
    Everything you need to know about Microbiota & Dysbiosis
    27.07.2022

    Everything you need to know about Dysbiosis

    Read the article
    28.12.2021

    Gut microbiota and chemotherapy: adverse effects or better treatment efficacy?

    Read the article
    25.11.2021

    Using meconium to predict allergy

    Read the article
    Photo: WAAW 2022 (HCPs)
    25.10.2022

    Microbiota at the forefront of antibiotic resistance

    Read the article
    Photo: Dermatite atopique : le mycobiote cutané à la loupe
    12.10.2022

    Atopic dermatitis: skin mycobiota under the microscope

    Read the article
    19.03.2024

    Itchiness: learning about the mechanism of action of S.aureus from scratch

    Read the article
    14.11.2023

    Immunotherapy coupled with FMT in patients with refractory melanoma: a Phase I trial

    Read the article
    28.10.2021

    6 things you should know about antibiotics

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish
    • Turkish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo